Timothy S. Ernst

General Counsel, Bio-Rad Laboratories.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

Trade performance

DateStockTradeValueReturn sinceVs S&P sinceVs S&P, 1 year
Feb 28, 2024BIOSale$826.4K+7.1%+45.4%+35.2%
Aug 30, 2023BIOSale$929.7K−10.9%+82.0%+39.7%
Aug 23, 2023BIOSale$115.4K−8.4%+82.6%+45.2%
Mar 8, 2023BIOSale$849.3K−26.5%+120.0%+58.5%
Aug 4, 2021BIOSale$248.6K−53.6%+129.4%+23.6%
Feb 19, 2021BIOSale$591.5K−44.5%+142.4%+18.6%
Dec 4, 2019BIOSale$705.4K−4.8%+152.6%−31.3%
Aug 14, 2019BIOSale$99.2K+12.0%+159.9%−42.8%
May 16, 2019BIOSale$149.8K+18.2%+150.1%−56.5%
May 15, 2019BIOSale$100.0K+20.2%+150.6%−55.5%

Returns are price-only (no dividends), measured from the trade date.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7